Lorne Park Announces Buyback of Royalties TORONTO, Nov.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
43
Lorne Park Announces Buyback of Royalties

TORONTO, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Lorne Park Capital Partners Inc. (TSXV:LPC) (“ LPCP ”) is pleased to announce that it has entered into agreements (“ Royalty Repurchase Agreements ”) to repurchase for cancellation two 5% royalties payable in respect of LPCP’s total consolidated annual revenue (each an “ Executive Royalty ”).

The Executive Royalties were originally granted by Bellwether Investment Management Inc. (“ Bellwether ”), LPCP’s operating subsidiary to Robert Sewell and Stephen Meehan, respectively, on April 1, 2013. The Royalty Repurchase Agreements provide for the purchase by LPCP of each Executive Royalty for 2,500,000 common shares at a deemed issue price of $0.40 per share, for total consideration of $1,000,000 per Executive Royalty.

LPCP has also repurchased a 10% royalty affecting the net revenue arising from certain adviser recruitment services provided by EWA Capital Partners Inc. (“ EWA ”) and retained LPCP and its subsidiaries (the “ EWA Royalty ”). The EWA Royalty was originally granted by LPCP to EWA effective January 1, 2015, and was amended effective August 1, 2016. LPCP repurchased the EWA Royalty for $1,250,000 in cash on November 21, 2017.

LPCP’s payment obligations pursuant to the Executive Royalties and EWA Royalty have rapidly increased as a result of revenue growth, and management expects such increases to continue. By repurchasing the Executive Royalties and EWA Royalty, LPCP will terminate variable payment obligations in exchange for one-time liquidated payments, resulting in potentially significant cost savings and permitting LPCP to conserve future revenue to fund growth and operations.

The direct or indirect interests of certain related parties of LPCP in the repurchase by LPCP of the Executive Royalties and the EWA Royalty constitute such transactions a “related party transaction” for the purposes of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“ MI 61-101 ”). Robert Sewell is the President and Chief Executive Officer, a director, and a control person of LPCP. Stephen Meehan, is the Chairman and a control person of LPCP, as well as a director, officer, and beneficial owner of EWA. Christopher Dingle, a director of LPCP, is a director of EWA. MI 61-101 requires that, unless exempted, a “related party transaction” is subject to certain formal valuation and minority shareholder approval requirements. LPCP is relying on exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 available because at the time the transactions were agreed to, neither the fair market value of, nor the fair market value of the consideration for, the Executive Royalties and the EWA Royalty, exceeded 25 per cent of LPCP’s market capitalization.

Pursuant to TSX Venture Exchange (“ TSXV ”) policies, the issuance of common shares to Messrs. Sewell and Meehan pursuant to the Royalty Repurchase Agreements is subject to the TSXV and disinterested shareholder approval. LPCP will seek disinterested shareholder approval at a special meeting of shareholders to be held on December 21, 2017. Assuming that such approvals are received and all other conditions are satisfied, the repurchase of the Executive Royalties will close on January 2, 2018, or such other date as may be agreed by LPCP and Mr. Sewell or Mr. Meehan, as applicable.  

About Lorne Park Capital Partners Inc.

LPCP was created to bring together boutique investment management and wealth advisory firms in order to deliver robust, cost effective investment solutions to affluent investors, foundations, estates and trusts. LPCP’s unique strategy creates better alignment between investment managers and wealth advisors while providing them with additional resources to accelerate their growth.

For further information, please contact:

Robert Sewell Chief Executive Officer Lorne Park Capital Partners Inc. bob.sewell@lpcp.ca (905) 337-2227

Cautionary Notes

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking information may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, “plan”, and other similar expressions. Forward looking information in this news release includes, without limitation, statements about TSXV and disinterested shareholder approvals, completion of the Executive Royalty repurchase transactions, expected benefits of repurchasing the Executive Royalties and the EWA Royalty, and LPCP’s objectives, goals and future plans. Forward-looking information addresses possible future events, conditions and financial performance based upon management's current expectations, estimates, projections and assumptions. In particular, the forward-looking information contained in this news release reflects assumptions about the timing and results of regulatory and disinterested shareholder approval of the Executive Royalty repurchase transactions. Management of LPCP considers the assumptions on which the forward-looking information contained herein are based to be reasonable. However, by its very nature, forward-looking information inherently involves known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such information. Such risks include, without limitation, failure to obtain regulatory or disinterested shareholder approvals. Accordingly, readers are cautioned not to place undue reliance on forward-looking information. LPCP disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 15

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

ANI Pharmaceuticals Plans to Shine at Biotech Conference

Updated Category News Views 257

ANI Pharmaceuticals Set for Key Presentation at Biotech Conference ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is gearing up to showcase its advancements at the Guggenheim Biotech Conference. On an exciting date, Nikhil Lalwani, the Company’s President and CEO, along with Stephen Carey, the CFO, will host a fireside chat to discuss the latest developments and future plans...

Continue Reading
New Shuttle Drives Economic Recovery on O'ahu

Updated Category News Views 26

Reviving the North Shore Economy, One Shuttle Ride at a Time Not every day do you see a $5 investment with such community punch. On June 29, a new bus service launches, whisking folks from Waik?k? and Ko Olina to O?ahu’s North Shore. But this ain't just another tourist bus ride—it's a lifeline for local businesses hit hard by March's kona low storms. Connecting...

Continue Reading
Virginia Cancer Specialists Expands Services with New Center

Updated Category News Views 21

Virginia Cancer Specialists Expands its Reach with a New Center Virginia Cancer Specialists, a leading private cancer practice in the region, has announced the opening of their newly expanded cancer center. This important development aims to enhance patient care and provide access to the latest cancer treatments. The expansion not only signifies growth but also a...

Continue Reading
Key Financial Dates for TCM Group A/S's Upcoming Year

Updated Category News Views 167

Important Financial Calendar for TCM Group A/S TCM Group A/S is a significant player in the kitchen and furniture manufacturing industry. As the year approaches its end, the company has established key dates for reporting and annual meetings, signaling to shareholders and stakeholders the importance of staying informed. Scheduled Report Releases and Meetings The Board of...

Continue Reading
Unexpected Chicago PMI Falls Raises Concerns for Manufacturing

Updated Category News Views 323

Understanding the Recent Chicago PMI Decline Recently, the Chicago Purchasing Managers' Index (PMI) reported a surprising score of 36.9, highlighting ongoing challenges in the manufacturing sector within the region. This score is a clear indication that the manufacturing landscape in Chicago is experiencing significant contraction, a worrisome sign for the local and...

Continue Reading